Two Sigma Advisers
DARE icon

Two Sigma Advisers’s Dare Bioscience DARE Stock Holding History

Two Sigma Advisers’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,900
Closed -$34.5K – 564
2025
Q4 		$34.5K Buy
+17,900
New +$35.7K ﹤0.01% 2295
2022
Q1 		– Sell
-2,867
Closed -$69K – 2772
2021
Q4 		$69K Buy
+2,867
New +$59K ﹤0.01% 2451
2021
Q3 		– Sell
-2,750
Closed -$62K – 2481
2021
Q2 		$62K Sell
2,750
-7,633
-74% -$130K ﹤0.01% 2372
2021
Q1 		$211K Buy
10,383
+750
+8% +$18.3K ﹤0.01% 2345
2020
Q4 		$155K Buy
+9,633
New +$135K ﹤0.01% 2214

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers's DARE Position: Q1 2026 in Review

Two Sigma Advisers sold out of Dare Bioscience (DARE) in Q1 2026, closing a stake of 17,900 shares — an estimated $34.5K sold.

Two Sigma Advisers first reported a position in DARE in Q4 2020 and held it in 5 quarters. The position peaked at $211K in Q1 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Two Sigma Advisers reported no remaining Dare Bioscience position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 17,900 Dare Bioscience shares in Q1 2026, an estimated $34.5K.
  • Two Sigma Advisers first reported a position in Dare Bioscience in Q4 2020 and held it in 5 quarters.
  • Two Sigma Advisers's Dare Bioscience position peaked at $211K in Q1 2021.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.